Walgreens Settles $106.8M for False Billing Allegations

The pharmacy chain was accused of billing federal health care programs for prescriptions that were never picked up by patients.

Walgreens will pay $106.8 million to settle claims of violating the False Claims Act and state statutes.
The allegations cover the period from 2009 to 2020, during which Walgreens billed Medicare, Medicaid, and other federal programs for uncollected prescriptions.
The settlement resolves three federal cases in New Mexico, Texas, and Florida initiated by whistleblowers.
Walgreens has already refunded $66.32 million and updated its electronic pharmacy management system to prevent future errors.
The whistleblowers, former Walgreens employees, will receive a combined total of $16.54 million for their roles in the investigation.